Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtered by score tier "Elite", market "China A-shares", profit streak "Full 10 yr": 58 match(clear filters).

#	Ticker	Mkt Cap	Score▼	10Y ROE	Profit Streak	Net Debt/Eq	Gross Margin	Report	FY
1	Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 300760 · Shenzhen	$27B	95/100 Elite	30.1%low 21.4%	10 yr+	Net cash	64%	Mindray Bio-Medical: The Transition Is Real, But So Is the Price TagJul 19, 2026 · Hold	FY2025
2	Kweichow Moutai Co Ltd 600519 · Shanghai	$236B	93/100 Elite	30.8%low 22.9%	10 yr+	Net cash	90%	Kweichow Moutai: A Long-Term Business Owner's PerspectiveMay 21, 2026 · Watch	FY2025
3	Shenzhen New Industries Biomedical 300832 · Shenzhen	$5.3B	93/100 Elite	23.5%low 17.4%	10 yr+	Net cash	75%	—	FY2025
4	Proya Cosmetics Co Ltd Class A 603605 · Shanghai	$3.3B	93/100 Elite	22.1%low 13.8%	10 yr+	Net cash	66%	—	FY2025
5	Foshan Haitian Flavouring and Food Co Ltd 603288 · Shanghai	$31B	92/100 Elite	26.3%low 17.0%	10 yr+	Net cash	41%	—	FY2025
6	Zhejiang Weixing New Building Materials Co Ltd 002372 · Shenzhen	$2.0B	92/100 Elite	23.9%low 15.2%	10 yr+	Net cash	43%	—	FY2025
7	Gongniu Group Co Ltd 603195 · Shanghai	$11B	91/100 Elite	36.5%low 24.2%	10 yr+	Net cash	41%	—	FY2025
8	Jiangsu King's Luck Brewery Joint-Stock Co Ltd 603369 · Shanghai	$5.0B	91/100 Elite	19.7%low 15.7%	10 yr+	Net cash	74%	—	FY2025
9	Hubei Jumpcan Pharmaceutical Co Ltd 600566 · Shanghai	$3.4B	91/100 Elite	21.6%low 12.2%	10 yr+	Net cash	83%	—	FY2025
10	Hangzhou Robam Appliances Co Ltd 002508 · Shenzhen	$2.1B	90/100 Elite	19.8%low 10.9%	10 yr+	Net cash	53%	—	FY2025
11	Yealink Network Technology Corp Ltd 300628 · Shenzhen	$6.9B	89/100 Elite	28.7%low 20.6%	10 yr+	Net cash	67%	—	FY2025
12	Midea Group Co Ltd 000333 · Shenzhen	$94B	88/100 Elite	22.1%low 17.8%	10 yr+	Net cash	26%	—	FY2025
13	Hangzhou Hikvision Digital Technology Co Ltd 002415 · Shenzhen	$48B	88/100 Elite	23.9%low 14.8%	10 yr+	Net cash	49%	—	FY2025
14	Inner Mongolia Yili Industrial Group Co Ltd 600887 · Shanghai	$24B	88/100 Elite	21.5%low 15.9%	10 yr+	Net cash	34%	—	FY2025
15	Zhangzhou Pientzehuang Pharmaceutical Co Ltd 600436 · Shanghai	$12B	88/100 Elite	20.3%low 14.8%	10 yr+	Net cash	44%	—	FY2025
16	Anhui Gujing Distillery Co Ltd 000596 · Shenzhen	$7.0B	88/100 Elite	18.6%low 13.9%	10 yr+	Net cash	77%	—	FY2025
17	CoCreation Grass Co Ltd 605099 · Shanghai	$1.9B	88/100 Elite	27.8%low 17.3%	10 yr+	Net cash	33%	—	FY2025
18	Gree Electric Appliances Inc of Zhuhai 000651 · Shenzhen	$33B	87/100 Elite	24.9%low 19.3%	10 yr+	Net cash	29%	—	FY2025
19	Hithink RoyalFlush Info Network 300033 · Shenzhen	$25B	87/100 Elite	26.7%low 19.0%	10 yr+	Net cash	90%	—	FY2025
20	Henan Shuanghui Investment & Development Co Ltd 000895 · Shenzhen	$13B	87/100 Elite	27.6%low 21.3%	10 yr+	Net cash	17%	—	FY2025
21	Anker Innovations Technology Co Ltd 300866 · Shenzhen	$10B	87/100 Elite	26.6%low 15.9%	10 yr+	Net cash	45%	—	FY2025
22	Anhui Yingjia Distillery Co Ltd 603198 · Shanghai	$4.4B	87/100 Elite	21.0%low 16.2%	10 yr+	Net cash	66%	—	FY2025
23	HLA GROUP CORP LTD 600398 · Shanghai	$4.2B	87/100 Elite	19.8%low 11.8%	10 yr+	Net cash	39%	—	FY2025
24	Henan Lingrui Pharmaceutical Co Ltd 600285 · Shanghai	$1.8B	87/100 Elite	16.6%low 10.0%	10 yr+	Net cash	74%	—	FY2025
25	Shanxi Xinghuacun Fen Wine Factory Co Ltd 600809 · Shanghai	$22B	86/100 Elite	29.0%low 12.7%	10 yr+	Net cash	72%	—	FY2025
26	Aier Eye Hospital Group 300015 · Shenzhen	$12B	86/100 Elite	17.4%low 14.2%	10 yr+	Net cash	49%	—	FY2025
27	Hebei Yangyuan ZhiHui Beverage Co Ltd 603156 · Shanghai	$6.8B	86/100 Elite	21.0%low 12.8%	10 yr+	Net cash	48%	—	FY2025
28	Zhejiang Supor Co Ltd 002032 · Shenzhen	$4.8B	86/100 Elite	28.8%low 23.7%	10 yr+	Net cash	26%	—	FY2025
29	Xiamen Faratronic Co Ltd 600563 · Shanghai	$4.3B	86/100 Elite	20.2%low 17.3%	10 yr+	Net cash	39%	—	FY2025
30	Livzon Pharmaceutical Group Inc 000513 · Shenzhen	$3.9B	86/100 Elite	16.0%low 10.2%	10 yr+	Net cash	63%	—	FY2025
31	Shanghai M&G Stationery Inc 603899 · Shanghai	$3.0B	86/100 Elite	20.8%low 14.1%	10 yr+	Net cash	23%	—	FY2025
32	Shanghai Flyco Electrical Appliance Co Ltd 603868 · Shanghai	$1.9B	86/100 Elite	25.0%low 15.1%	10 yr+	Net cash	46%	—	FY2025
33	G-bits Network Technology Xiamen Co Ltd 603444 · Shanghai	$3.9B	84/100 Elite	28.1%low 19.3%	10 yr+	Net cash	90%	—	FY2025
34	Jiangzhong Pharmaceutical Co Ltd 600750 · Shanghai	$2.3B	84/100 Elite	15.8%low 12.2%	10 yr+	Net cash	66%	—	FY2025
35	Jafron Biomedical Co Ltd 300529 · Shenzhen	$2.1B	84/100 Elite	23.3%low 13.9%	10 yr+	Net cash	83%	—	FY2025
36	Jiangsu Hengrui Medicine Co Ltd 600276 · Shanghai	$50B	83/100 Elite	16.5%low 10.3%	10 yr+	Net cash	86%	Hengrui Pharmaceuticals: A Fortress Innovation Platform, But RMB 50 Already Pays for the UpgradeJun 26, 2026 · Hold	FY2025
37	Luzhou Lao Jiao Co Ltd 000568 · Shenzhen	$19B	83/100 Elite	24.6%low 16.9%	10 yr+	Net cash	81%	—	FY2025
38	Huadong Medicine Co Ltd 000963 · Shenzhen	$7.1B	83/100 Elite	17.6%low 13.5%	10 yr+	Net cash	30%	—	FY2025
39	Lao Feng Xiang Co Ltd A 600612 · Shanghai	$2.6B	83/100 Elite	18.4%low 11.6%	10 yr+	Net cash	8%	—	FY2025
40	Foxconn Industrial Internet Co Ltd 601138 · Shanghai	$158B	82/100 Elite	22.0%low 15.0%	10 yr+	Net cash	8%	FII Zen Horizon Research: No. 1 in AI server rack assembly, real earnings acceleration, but a thin business at a rich valuationJun 4, 2026 · Watch	FY2025
41	Suzhou TFC Optical Communication Co Ltd 300394 · Shenzhen	$26B	82/100 Elite	19.9%low 12.7%	10 yr+	Net cash	53%	T&S Communications: A Real Upstream Bottleneck, Priced as if Scarcity Economics Were PermanentJul 28, 2026 · Avoid	FY2025
42	Avic Shenyang Aircraft Co Ltd 600760 · Shanghai	$17B	82/100 Elite	19.2%low 9.5%	10 yr+	Net cash	10%	—	FY2025
43	Shandong Himile Mechanical Science & Technology Co Ltd 002595 · Shenzhen	$8.5B	82/100 Elite	18.1%low 16.2%	10 yr+	Net cash	33%	—	FY2025
44	Chongqing Brewery Co Ltd 600132 · Shanghai	$3.1B	82/100 Elite	49.8%low 14.7%	10 yr+	Net cash	46%	—	FY2025
45	Dashenlin Pharm Grp Co Ltd 603233 · Shanghai	$3.0B	82/100 Elite	18.2%low 13.3%	10 yr+	0.0×	38%	—	FY2025
46	MicroPort Endovascular MedTech Ltd 688016 · Shanghai	$1.6B	82/100 Elite	22.2%low 12.8%	10 yr+	Net cash	79%	—	FY2025
47	Yindu Kitchen Equipment Co Ltd 603277 · Shanghai	$937M	82/100 Elite	18.3%low 12.7%	10 yr+	Net cash	41%	—	FY2025
48	NARI Technology Co Ltd 600406 · Shanghai	$27B	81/100 Elite	15.3%low 14.2%	10 yr+	Net cash	27%	NARI Technology: Grid-Control Franchise, Quality Already PricedJun 27, 2026 · Hold	FY2025
49	Shanghai Friendess Electronics Tech 688188 · Shanghai	$5.9B	81/100 Elite	27.3%low 11.2%	10 yr+	Net cash	82%	—	FY2025
50	Hisense Kelon Electrical Holdings Co Ltd 000921 · Shenzhen	$5.3B	81/100 Elite	19.1%low 9.4%	10 yr+	Net cash	21%	—	FY2025
51	Shanghai Huace Navigation Technology Ltd 300627 · Shenzhen	$3.2B	81/100 Elite	17.0%low 12.2%	10 yr+	Net cash	60%	—	FY2025
52	AIMA Technology Group Co Ltd 603529 · Shanghai	$2.7B	81/100 Elite	25.4%low 13.3%	10 yr+	Net cash	15%	—	FY2025
53	Opple Lighting Co Ltd 603515 · Shanghai	$1.8B	81/100 Elite	15.8%low 12.9%	10 yr+	Net cash	37%	—	FY2025
54	Warom Technology Inc Co 603855 · Shanghai	$794M	81/100 Elite	16.7%low 8.9%	10 yr+	Net cash	51%	—	FY2025
55	Runner Xiamen Corp 603408 · Shanghai	$650M	81/100 Elite	20.1%low 12.8%	10 yr+	Net cash	26%	—	FY2025
56	China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000999 · Shenzhen	$6.0B	80/100 Elite	14.4%low 11.6%	10 yr+	Net cash	60%	—	FY2025
57	Jiangsu Nhwa Pharmaceutical Co Ltd 002262 · Shenzhen	$3.1B	80/100 Elite	16.2%low 13.1%	10 yr+	Net cash	66%	—	FY2025
58	Dalian Bio-Chem Co Ltd 603360 · Shanghai	$1.2B	80/100 Elite	21.2%low 14.6%	10 yr+	Net cash	48%	—	FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.